Product
FKS518
1 clinical trial
1 indication
Indication
OsteoporosisClinical trial
A Double-blind, Randomized, Multicenter, Multiple-dose, 2-arm, Parallel-group Study to Evaluate Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 - Proposed Biosimilar to Denosumab With Prolia® in Postmenopausal Women With Osteoporosis (LUMIADE-3 Study)Status: Completed, Estimated PCD: 2023-08-07